Trending Topic

14 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Kate Clair Cruden Hughes, Amy Hai Yan Chan

Asthma affects nearly 300 million people worldwide.1 Despite a notable decline in age-standardized prevalence, mortality and disability-adjusted life years over the past three decades, the burden of asthma remains high in many countries including low-middle-income countries.2 Climate change is also predicted to significantly impact asthma and other respiratory-related conditions, as rising global temperatures lead to longer pollen […]

Larry Corey, IAS COVID-19 2021: SARS-CoV2 Vaccine Candidates

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Mar 4th 2021

We had the pleasure of speaking with Larry Corey (Fred Hutchinson Cancer Research Center, Seattle, WA, USA) to discuss the current status of SARS-CoV2 vaccine candidates.

His talk entitled: ‘Update on SARS-CoV2 vaccine candidates: What do the data show?’ was presented at the IAS COVID-19 Conference: Prevention 2021, 02 February 2021.

Questions:

  1. What are the most useful target antigens for SARS-CoV2 vaccine? (0:06)
  2. What have we learned from the development of the currently approved vaccines, and which candidates seem most promising? (0:55)
  3. What is the current status of the clinical development of these candidates? (1:32)

Disclosures: Larry Corey has nothing to disclose in relation to this video.

Support: Interview and filming supported by Touch Medical Media.

Filmed as a highlight of IAS COVID-19 Conference: Prevention (Virtual) 2021.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup